BioLife Solutions, Inc.
BLFS
$35.07
-$0.16-0.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3,703.04% | -- | -- | 103.92% | -3,435.27% |
| Total Depreciation and Amortization | 15.74% | -- | -- | 150.94% | 4.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -916.94% | -- | -- | -68.40% | 316.23% |
| Change in Net Operating Assets | 59.86% | -- | -- | -3,616.47% | 102.26% |
| Cash from Operations | 1,392.87% | -- | -- | -17.16% | 326.64% |
| Capital Expenditure | -524.55% | -- | -- | -92.91% | -348.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 67.77% | -- | -- | 93.91% | -40.66% |
| Cash from Investing | 13.72% | -- | -- | 84.91% | -45.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -- | -- | 0.00% | 0.00% |
| Issuance of Common Stock | -98.42% | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | 80.37% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -- | 85.35% | 19.51% |
| Cash from Financing | 54.48% | -- | -- | 11.12% | 3.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 111.50% | -- | -- | 93.09% | -23.21% |